|
|
Volumn 6, Issue 2, 2011, Pages 76-
|
|
Foreword
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
CALCIUM ION;
POTASSIUM ION;
THIORIDAZINE;
TUBERCULOSTATIC AGENT;
BACTERIAL GENE;
BACTERIAL STRAIN;
BACTERIAL SURVIVAL;
BACTERICIDAL ACTIVITY;
CALCIUM TRANSPORT;
CLINICAL EFFECTIVENESS;
DRUG EFFECT;
DRUG MECHANISM;
DRUG RESEARCH;
DRUG SAFETY;
DRUG TARGETING;
EDITORIAL;
EXTENSIVELY DRUG RESISTANT TUBERCULOSIS;
GENE EXPRESSION REGULATION;
HUMAN;
IN VITRO STUDY;
LIFE EXTENSION;
MULTIDRUG RESISTANT TUBERCULOSIS;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
PHARMACOLOGICAL BLOCKING;
PHENOTYPE;
POTASSIUM TRANSPORT;
PRIORITY JOURNAL;
PROGNOSIS;
QUALITY OF LIFE;
SALVAGE THERAPY;
TUBERCULOSIS CONTROL;
ANIMAL;
DRUG COMBINATION;
DRUG DEVELOPMENT;
MICROBIOLOGY;
MULTIDRUG RESISTANCE;
PATHOGENICITY;
TREATMENT FAILURE;
ANIMALS;
ANTITUBERCULAR AGENTS;
DRUG DISCOVERY;
DRUG RESISTANCE, MULTIPLE, BACTERIAL;
DRUG THERAPY, COMBINATION;
EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS;
HUMANS;
MYCOBACTERIUM TUBERCULOSIS;
THIORIDAZINE;
TREATMENT FAILURE;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
|
|
EID: 79960027088
PISSN: 1574891X
EISSN: None
Source Type: Journal
DOI: 10.2174/157489111796064605 Document Type: Editorial |
|
Times cited : (2)
|
|
References (0)
|
